Charlene Kay

Estrogen Receptor and Progesterone Receptor As Predictive Biomarkers of Response to Endocrine Therapy: A Prospectively Powered Pathology Study in the Tamoxifen and Exemestane Adjuvant Multinational Trial

John M.S. Bartlett, Cassandra Brookes, Tammy Robson et al. · Journal of Clinical Oncology · 2011 · 198 citations · Full text

Medicine, Oncology, Pathology +17

Systems Biology Reveals New Strategies for Personalizing Cancer Medicine and Confirms the Role of PTEN in Resistance to Trastuzumab

Dana Faratian, Alexey Goltsov, Galina Lebedeva et al. · Cancer Research · 2009 · 160 citations · Full text

Medicine, Oncology, Systems Biology +17

Accurate Prediction and Validation of Response to Endocrine Therapy in Breast Cancer

Arran Turnbull, Laura Arthur, Lorna Renshaw et al. · Journal of Clinical Oncology · 2015 · 117 citations · Full text

Medicine, Endocrinology, Oncology +17

Evaluation of carbonic anhydrase IX as a therapeutic target for inhibition of breast cancer invasion and metastasis using a series of<i>in vitro</i>breast cancer models

Carol Ward, James Meehan, Peter Mullen et al. · Oncotarget · 2015 · 96 citations · Full text

Medicine, Molecular Biology, Oncology +16

Trastuzumab and Pertuzumab Produce Changes in Morphology and Estrogen Receptor Signaling in Ovarian Cancer Xenografts Revealing New Treatment Strategies

Dana Faratian, Annelien J.M. Zweemer, Yoko Nagumo et al. · Clinical Cancer Research · 2011 · 63 citations · Full text

Medicine, Oncology, Pharmacology +17